• OPEN AN ACCOUNT
Indian Indices
Nifty
26,186.45 152.70
(0.59%)
Sensex
85,712.37 447.05
( 0.52%)
Bank Nifty
59,777.20 488.50
( 0.82%)
Nifty IT
38,703.65 343.40
( 0.90%)
Global Indices
Nasdaq
47,981.01 109.07
(0.23%)
Dow Jones
6,892.33 14.21
(0.21%)
Hang Seng
50,440.45 -587.97
(-1.15%)
Nikkei 225
9,667.01 -43.86
(-0.45%)
Forex
USD-INR
89.99 -0.14
(-0.16%)
EUR-INR
104.92 -0.11
(-0.11%)
GBP-INR
120.05 0.29
(0.24%)
JPY-INR
0.58 0.00
(0.11%)

EQUITY - MARKET SCREENER

Hindalco Industries Ltd
Industry :  Aluminium and Aluminium Products
BSE Code
ISIN Demat
Book Value()
500440
INE038A01020
326.0851632
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HINDALCO
25.86
184980.45
EPS(TTM)
Face Value()
Div & Yield %
31.83
1
0.6
 

Abbott India gets central govt nod to appoint Kartik Rajendran as MD
Nov 25,2025

His tenure will be for a period of five years, effective from 14 June 2025, to 13 June 2030.

The appointment is expected to provide continued strategic leadership and drive growth initiatives for the company in the coming years.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Abbott India’s standalone net profit climbed 15.79% to Rs 415.27 crore on 7.62% increase in revenue from operations to Rs 1,757.15 crore in Q2 FY26 over Q2 FY25.

Shares of Abbott India shed 0.63% to currently trade at Rs 29,536.05 on the BSE.